Gilead Sciences (GILD)
Salud · Farmacéuticas y biotecnología · USA
$170.95
+3.24%
Acerca de
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.
Fuente: Wikipedia · CC BY-SA 4.0
Sector
Healthcare
Sitio web
www.gilead.comComparación con Índices
| Período | GILD | Dow Jones | Nasdaq | S&P 500 |
|---|---|---|---|---|
| 1D | +3.06% | -1.09%(+4.2) | -2.86%(+5.9) | -1.82%(+4.9) |
| 1W | +9.38% | -0.85%(+10.2) | -2.00%(+11.4) | -0.57%(+10.0) |
| 1M | +15.72% | +1.66%(+14.1) | -5.34%(+21.1) | -1.13%(+16.9) |
| YTD | +40.36% | +7.00%(+33.4) | +9.47%(+30.9) | +10.52%(+29.8) |
| 1Y | +42.48% | +8.85%(+33.6) | +7.22%(+35.3) | +10.82%(+31.7) |
Los números entre paréntesis muestran el rendimiento relativo vs el índice
Cierre anterior$165.61
Apertura$170.25
Rango del día$169.00 - $175.65
Rango 52 semanas$116.88 - $175.65
Volumen11.43M
Volumen prom.6.12M
Capitalización$212B
Beta (5A)0.33
BPA$-3.13
Ratio P/B17.93x
Rendimiento dividendo1.90%
Ingresos$31B
Ganancia neta-$3.9B
Margen operativo37.8%
Deuda total$26B
Efectivo$3.2B
Objetivo 1 año$172.50